| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |